CME Group Inc. (NASDAQ:CME – Get Free Report) CEO Terrence Duffy sold 27,000 shares of the stock in a transaction on Wednesday, November 18th. The shares were sold at an average price of $309.57, for a total value of $8,358,390.00. Following the completion of the transaction, the chief executive officer directly owned 35,442 shares in the company, valued at approximately $10,971,779.94. This trade represents a 43.24% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
CME Group Stock Down 1.3%
Shares of CME Group stock traded down $3.94 on Thursday, hitting $306.31. The company had a trading volume of 2,451,943 shares, compared to its average volume of 2,467,037. The firm has a market capitalization of $109.64 billion, a P/E ratio of 25.13, a P/E/G ratio of 3.80 and a beta of 0.15. CME Group Inc. has a twelve month low of $218.31 and a twelve month high of $329.16. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a 50-day moving average of $288.15 and a 200-day moving average of $281.93.
CME Group (NASDAQ:CME – Get Free Report) last released its earnings results on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share for the quarter, beating the consensus estimate of $2.99 by $0.03. The business had revenue of $1.74 billion during the quarter, compared to analysts’ expectations of $1.71 billion. CME Group had a net margin of 63.33% and a return on equity of 16.23%. The firm’s revenue was up 10.6% on a year-over-year basis. During the same period last year, the business earned $2.68 earnings per share. Research analysts predict that CME Group Inc. will post 12.35 earnings per share for the current year.
CME Group Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 30th. Stockholders of record on Friday, December 11th will be given a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date of this dividend is Friday, December 11th. CME Group’s payout ratio is presently 42.66%.
Institutional Trading of CME Group
Several institutional investors have recently modified their holdings of the business. First Community Trust NA acquired a new position in CME Group during the 3rd quarter worth about $26,000. North Point Portfolio Managers Corp OH acquired a new stake in shares of CME Group in the third quarter valued at about $26,000. Tanglewood Legacy Advisors LLC acquired a new stake in shares of CME Group in the third quarter valued at about $26,000. Mowery & Schoenfeld Wealth Management LLC acquired a new stake in shares of CME Group in the second quarter valued at about $28,000. Finally, Compass Financial Management LLC raised its position in shares of CME Group by 471.4% during the third quarter. Compass Financial Management LLC now owns 120 shares of the financial services provider’s stock worth $31,000 after acquiring an additional 99 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.
Analysts Set New Price Targets
A number of research firms have recently weighed in on CME. Wells Fargo & Company upped their target price on CME Group from $315.00 to $333.00 and gave the company an “overweight” rating in a research report on Thursday, October 22nd. UBS Group upped their price objective on shares of CME Group from $270.00 to $310.00 and gave the stock a “neutral” rating in a research report on Thursday, October 22nd. Morgan Stanley increased their price objective on shares of CME Group from $337.00 to $359.00 and gave the stock an “overweight” rating in a research note on Thursday, October 22nd. Wall Street Zen upgraded shares of CME Group from a “sell” rating to a “hold” rating in a research report on Saturday, October 31st. Finally, Barclays upped their price target on shares of CME Group from $281.00 to $321.00 and gave the stock an “equal weight” rating in a report on Thursday, October 22nd. Ten equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $314.44.
Check Out Our Latest Stock Analysis on CME
About CME Group
CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.
Recommended Stories
- Five stocks we like better than CME Group
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
